Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2,644 INR | -1.11% | +1.04% | +2.59% |
05-14 | Nomura Upgrades Dr. Lal Pathlabs to Buy From Neutral, Adjusts Price Target to INR2,713 From INR2,505 | MT |
05-13 | Dr. Lal Pathlabs' Fiscal Q4 Consolidated Net Profit Rises; Share Up 6% | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+2.59% | 2.67B | |
-25.06% | 7.76B | |
+68.65% | 4.35B | |
-2.10% | 2.64B | |
-47.63% | 2.1B | |
-16.74% | 1.73B | |
-19.62% | 1.52B | |
+14.52% | 1.18B | |
-45.53% | 1.11B | |
+16.55% | 997M |
- Stock Market
- Equities
- LALPATHLAB Stock
- News Dr. Lal PathLabs Limited
- Transcript : Dr. Lal PathLabs Limited, Q4 2024 Earnings Call, May 10, 2024